0001209191-18-004356.txt : 20180118
0001209191-18-004356.hdr.sgml : 20180118
20180118180305
ACCESSION NUMBER: 0001209191-18-004356
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180116
FILED AS OF DATE: 20180118
DATE AS OF CHANGE: 20180118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SELICK HAROLD E
CENTRAL INDEX KEY: 0001287233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 18534983
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6507450655
MAIL ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-16
0
0001124105
CATALYST BIOSCIENCES, INC.
CBIO
0001287233
SELICK HAROLD E
260 LITTLEFIELD AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
157.20
2018-01-16
4
D
0
197
0.00
D
2020-05-13
Common Stock
197
0
D
Stock Option (Right to Buy)
157.20
2018-01-16
4
A
0
197
0.00
A
2018-01-16
2020-07-11
Common Stock
197
197
D
Stock Option (Right to Buy)
66.00
2018-01-16
4
D
0
550
0.00
D
2025-10-22
Common Stock
550
0
D
Stock Option (Right to Buy)
66.00
2018-01-16
4
A
0
550
0.00
A
2018-01-16
2020-07-11
Common Stock
550
550
D
Stock Option (Right to Buy)
66.00
2018-01-16
4
D
0
450
0.00
D
2025-10-22
Common Stock
450
0
D
Stock Option (Right to Buy)
66.00
2018-01-16
4
A
0
450
0.00
A
2018-01-16
2020-07-11
Common Stock
450
450
D
Stock Option (Right to Buy)
28.20
2018-01-16
4
D
0
500
0.00
D
2026-06-09
Common Stock
500
0
D
Stock Option (Right to Buy)
28.20
2018-01-16
4
A
0
500
0.00
A
2018-01-16
2020-07-11
Common Stock
500
500
D
Stock Option (Right to Buy)
4.40
2018-01-16
4
D
0
10000
0.00
D
2018-06-15
2027-07-13
Common Stock
10000
0
D
Stock Option (Right to Buy)
4.40
2018-01-16
4
A
0
10000
0.00
A
2018-01-16
2020-07-11
Common Stock
10000
10000
D
Reflects a fifteen-for-one reverse stock split on February 10, 2017.
The option is fully vested and exercisable.
The reported transactions involved an amendment to the post-termination exercise period of outstanding options, resulting in the deemed cancellation of the vested options and the grant of replacement fully vested options.
/s/ Faisal Shawwa, Attorney-in-Fact for Harold E. Selick
2018-01-18